Gary Sutton

Gary Sutton is the current Chief Business Officer at Ribon Therapeutics. Prior to this, they held various positions at different companies, including VP, Discovery and Preclinical Research Oncology at Sanofi, Vice President, Biology at Epizyme, Inc., Senior Director at Merck, and Executive Director at Aton Pharma, Inc. Gary started their career as an Associate Lab Member at Memorial Sloan-Kettering Cancer Center in 1986.

Gary Sutton has a PhD in Biochemistry from the University of Nebraska Medical Center and a B.A. in Chemistry from the University of Vermont.

Gary Sutton reports to Prakash Raman, President & CEO. They work with Paul Brannelly - CFO, Kevin Kuntz - Chief Drug Development Officer, and Sally Johnson - Chief People Officer.